Item 2.02. Results of Operations and Financial Condition.
On
The information included under Item 2.02 of this current report on Form 8-K, including Exhibit 99.1, is deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and, therefore, may be incorporated by reference in filings under the Securities Act of 1933, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press Release ofEyePoint Pharmaceuticals, Inc. , datedJanuary 11, 2021 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source